11th Drug Discovery Innovation Programme (DDIP) in Munich, Germany

Pharmacology & Pharmaceuticals; Biotechnology & Biomedical

Address: Munich Airport Marriott Hotel, Alois Steinecker Strasse 20, Freising 85354 Germany
Date: 23 to 24 Apr '20
Visit Event Website

The Drug Discovery Innovation Programme (DDIP) has always proven to be a unique platform to meet senior-level executives, key decision-makers and experts all-around the Pharmaceutical, Biotech and Lead Scientists, making the congress the perfect platform to share experiences and foster collaborations to put forward many thought-provoking strategies.


  •  12+ Networking Hours
  •  25+ Countries Representation
  •  20+ Keynote Speakers 
  • 250+ Pre-Qualified meeting 
  • 75:25 Buyers:Sellers 
  • 80+ Attendees 

The 11th Drug Discovery Innovation Programme is Co-Located with the 15th Clinical Trials Innovation Programme (CTIP).

Key Themes & Topics

Here the experience of learning is different. With entrancing discussions about the most recent Innovations, trends and global challenges, DDIP is sure to cater to the unmet needs of the pharma industry.

Who Should Attend

Top-level Industry leaders from around 25+ Countries come to join DDIP and leave with an exceptional experience that they return to the conferences year after year. Delegates attending our event are asked to complete a questionnaire, which confirms their R&D budget. 

They also provide details on:
  •  Relevant Drug Discovery phases 
  • Drug Discovery budget of over 1 million Euros​ 
  • Scope of responsibility​ 
  • Purchase plan for Products and services 
  • Geographies of interest​ 
  • Key priorities for the next 6-18 months 

  • CEO 
  • CSO 
  • Director Discovery Alliances 
  • VP of Chemistry 
  • VP Target Discovery & Assessment 
  • Senior Director Discovery Research 
  • Senior Director Functional Genomics 
  • Head of R&D Licensing 
  • VP Pharmacology & Preclinical PK/PD 
  • Principal Scientist 
  • Head Pharmacology & Toxicology 
  • Director of Discovery Strategy Portfolio 
  • Executive Director Chemistry 
  • VP Translational Medicine 
  • Head of Drug Design


Get the latest updates



Erik Buntinx

Founding CEO


Gabriel Baverel

President and CSO


Luca Signorile

Computational Chemist

SOM Biotech

Marcel van Duin

Vice President, Head Research

Ferring Pharmaceuticals

Markus Muellner


PhoreMost Ltd

Nicolas Bery

Postdoctoral Scientist

University of Oxford

Wim Van Criekinge



Xavier Leroy

Chief Technology Officer (CTO)

Domain Therapeutics



Munich Airport Marriott Hotel

Get the latest updates


Munich Airport Marriott Hotel


World BI

 Please check the official event website for possible changes before you make any travel arrangements.
Prices are for evaluation only.